AIRLINK 205.81 Increased By ▲ 5.52 (2.76%)
BOP 10.24 Decreased By ▼ -0.25 (-2.38%)
CNERGY 7.06 Decreased By ▼ -0.15 (-2.08%)
FCCL 34.66 Decreased By ▼ -0.28 (-0.8%)
FFL 17.10 Decreased By ▼ -0.32 (-1.84%)
FLYNG 24.68 Decreased By ▼ -0.17 (-0.68%)
HUBC 131.18 Increased By ▲ 3.37 (2.64%)
HUMNL 13.98 Increased By ▲ 0.17 (1.23%)
KEL 4.91 Decreased By ▼ -0.09 (-1.8%)
KOSM 6.81 Decreased By ▼ -0.22 (-3.13%)
MLCF 44.34 Decreased By ▼ -0.28 (-0.63%)
OGDC 221.77 Decreased By ▼ -0.38 (-0.17%)
PACE 7.22 Decreased By ▼ -0.20 (-2.7%)
PAEL 42.69 Decreased By ▼ -0.11 (-0.26%)
PIAHCLA 17.13 Decreased By ▼ -0.26 (-1.5%)
PIBTL 8.42 Decreased By ▼ -0.09 (-1.06%)
POWER 9.09 Decreased By ▼ -0.06 (-0.66%)
PPL 190.86 Decreased By ▼ -1.87 (-0.97%)
PRL 43.49 Increased By ▲ 1.99 (4.8%)
PTC 24.79 Increased By ▲ 0.35 (1.43%)
SEARL 102.66 Increased By ▲ 1.39 (1.37%)
SILK 1.02 Decreased By ▼ -0.03 (-2.86%)
SSGC 42.74 Decreased By ▼ -1.13 (-2.58%)
SYM 18.40 Decreased By ▼ -0.36 (-1.92%)
TELE 9.26 Decreased By ▼ -0.28 (-2.94%)
TPLP 13.15 Increased By ▲ 0.07 (0.54%)
TRG 68.78 Increased By ▲ 2.59 (3.91%)
WAVESAPP 10.42 Decreased By ▼ -0.11 (-1.04%)
WTL 1.80 Increased By ▲ 0.02 (1.12%)
YOUW 4.00 Decreased By ▼ -0.04 (-0.99%)
BR100 12,034 Decreased By -5.6 (-0.05%)
BR30 36,777 Increased By 88.7 (0.24%)
KSE100 114,496 Decreased By -308.5 (-0.27%)
KSE30 36,003 Decreased By -99.2 (-0.27%)

KARACHI: Haleon Pakistan plans to start manufacturing multivitamin brand Centrum in the country for domestic sales and export, its CEO said, as the company seeks to boost sales amid lower inflation.

The Pakistan unit of British consumer healthcare firm Haleon plans to expand its pain management offerings next year by adding the Panadol range for menstrual pain and migraines, CEO Farhan Muhammad Haroon told Reuters in an interview.

“Pakistan has a Rs24-billion ($86.30 million) Vitamin Mineral Supplement market. This does not include the grey market. We already make up Rs7.5 billion ($26.97 million) of the market through our (vitamin) products CAC-1000 Plus and Qalsium-D,” said Haroon.

“With the launch of Centrum, we plan to capture 7 to 8% of remaining market immediately, which is a sizeable portion of the category.”

Pakistan’s Citi Pharma, Martin Dow partner with Chinese firm for biotech manufacturing

Haroon said the company plans to sell Centrum in smaller bottles so customers do not have to worry about high upfront costs, as purchasing power has diminished in the country after inflation hit a multidecade high of around 40% last year. In November, Pakistan’s consumer price index inflation slowed to 4.9%.

Haroon said in the first stage of the Centrum launch, expected in the first quarter of 2025, the product will be imported, and in the second stage it will be made locally with market specific variants to suit needs of Pakistanis and other export markets.

“We already export our calcium and vitamin D supplement CAC-1000 Plus and topical pain relief product Voltral Emulgel to Vietnam and Philippines, we will be ready to export to 19 countries in the next 1-1.5 years,” he said.

Haleon Pakistan sees at least 10% of its sales coming from exports in the next two years, up from 5%-6% during its peak in 2022, Haroon said, adding that it had invested $10 million last year to enhance local production capabilities.

Comments

200 characters